0000950170-23-005815.txt : 20230302 0000950170-23-005815.hdr.sgml : 20230302 20230302160301 ACCESSION NUMBER: 0000950170-23-005815 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230302 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230302 DATE AS OF CHANGE: 20230302 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Singular Genomics Systems, Inc. CENTRAL INDEX KEY: 0001850906 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 812948451 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40443 FILM NUMBER: 23698775 BUSINESS ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 333-7830 MAIL ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 8-K 1 omic-20230302.htm 8-K 8-K
0001850906false00018509062023-03-022023-03-02

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 2, 2023

 

 

Singular Genomics Systems, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware

001-40443

81-2948451

(State or other jurisdiction
of incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

3010 Science Park Road
San Diego, California 92121

 

(858) 333-7830
(Registrant’s address of principal executive offices

and telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of Each Class

 

Trading
Symbol(s)

 


Name of Each Exchange on Which Registered

Common Stock, par value $0.0001 per share

 

OMIC

 

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 2.02 Results of Operations and Financial Condition.

On March 2, 2023, Singular Genomics Systems, Inc. (the “Company”) issued a press release regarding the Company’s financial results for the quarter and year ended December 31, 2022. A copy of the press release is attached as Exhibit 99.1 and incorporated herein by reference.

The information in this Item 2.02 and the press release attached as Exhibit 99.1 hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit

Number

 

Description

99.1

 

Press Release dated March 2, 2023.

104

 

Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.




 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Singular Genomics Systems, Inc.

 

 

 

 

Dated:

March 2, 2023

By:

/s/ Dalen Meeter

 

 

 

Dalen Meeter
Chief Financial Officer
Principal Financial Officer and Principal Accounting Officer

 

 

 EX-99 2 omic-ex99_1.htm EX-99.1 EX-99

EX-99.1

 

img160378605_0.jpg 

 

Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results

 

San Diego, CA, March 2, 2023 – Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended December 31, 2022.

 

“2022 was a pivotal year for Singular Genomics. It was a year in which we achieved important milestones, overcame challenges, and ultimately ended on a strong note with five G4 systems in market. Most importantly, the business is set up for success with the right team, the right product, and the right opportunity. I am tremendously proud of the entire Singular team," said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics. “In 2023, we will remain focused on customer success across a growing installed base, commercial and operational execution, and advancing our innovation pipeline.”

 

Fourth Quarter and Recent Highlights

•
Generated the company’s first quarter of revenue of $765 thousand for the fourth quarter of 2022
•
Shipped four G4 systems to new customers in the fourth quarter of 2022, bringing our total commercial systems shipped to five as of the end of 2022
•
Launched Max Read kits for single cell sequencing, with an expected ship date in the second quarter, which boosts the potential output of the G4 to 800 million reads per flow cell, or a market-leading 3.2 billion reads per run on a benchtop system
•
Joined the 10x Genomics Compatible Partner Program, demonstrating compatibility of the G4 sequencing platform with 10x Genomics’ single cell applications
•
Increased the quality specifications for the G4 to 80%–90% Q30
•
Raised the throughput range of the F2 and F3 flow cells to up to 250 million and up to 450 million reads, respectively
•
Produced 14 new data sets, 11 with industry-leading genomics partners, showcasing high accuracy of the G4 across many diverse applications

 

Fourth Quarter 2022 Financial Results

Revenue for the fourth quarter of 2022 was $765 thousand, marking the first revenue generating quarter. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the quarter. Operating expenses for the fourth quarter of 2022 totaled $22.5 million, compared to $19.7 million for the fourth quarter of 2021. Operating expenses included non-cash stock-based compensation of $3.1 million for the fourth quarter of 2022 and $2.9 million for the fourth quarter of 2021. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap.

 

Net loss for the fourth quarter of 2022 was $21.1 million, or a loss of $0.29 per common share, compared to $19.8 million, or a loss of $0.27 per common share, in the fourth quarter of 2021

 

 

EX-99.1

 

img160378605_0.jpg 

Full Year 2022 Financial Results

Revenue for the full year of 2022 was $765 thousand. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the fourth quarter. Operating expenses for 2022 totaled $93.5 million compared to $61.3 million in the prior year period. Operating expenses included non-cash stock-based compensation expense of $13.7 million in 2022 and $9.2 million in 2021. The year-over-year increase in total operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap, and the costs associated with being a public company.

 

Net loss for 2022 was $90.9 million, or a loss of $1.28 per common share, compared to $98.8 million, or a loss of $2.10 per common share, in 2021.

 

Cash, cash equivalents and short-term investments, excluding restricted cash, as of December 31, 2022 totaled $244.6 million.

 

Webcast and Conference Call Details

Singular Genomics’ management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section.

 

About Singular Genomics Systems, Inc.

Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In development, the PX system leverages Singular’s proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. With these products, Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine. Visit www.singulargenomics.com for more information.

 

 

EX-99.1

 

img160378605_0.jpg 

Forward-Looking Statements

Certain statements contained in this press release, other than historical information, constitute forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include and are not limited to statements regarding: (i) our ability to successfully manufacture and commercialize the G4 in accordance with our timelines, objectives and specifications; (ii) our ability to successfully ship G4 systems on our timeline; (iii) our ability to achieve customer and scientific acceptance of the G4; (iv) the ability of our product offerings to successfully compete with existing and new products offered by our competitors; and (v) quotes of management. Any such forward-looking statements are based on our management’s current expectations and are subject to risks and uncertainties that could cause our actual future results to differ materially from our management’s current expectations or those implied by our forward-looking statements. These risks and uncertainties include and are not limited to the following: (i) we have incurred significant losses since inception, we expect to incur significant losses in the future and we may not be able to generate sufficient revenue to achieve and maintain profitability; (ii) we have very little history manufacturing and commercializing our products or technology; (iii) the life sciences technology market is highly competitive, and if we fail to compete effectively, our business and operating results will suffer; (iv) if we are sued for infringing, misappropriating or otherwise violating intellectual property rights of third parties, such litigation could be costly and time consuming and could prevent or delay us from developing or commercializing our products; (v) if our products fail to achieve early customer and scientific acceptance, we may not be able to achieve broader market acceptance for our products, and our revenues and prospects may be harmed; (vi) we expect to be highly dependent upon revenue generated from the sale of the G4 and planned PX, and any delay or failure by us to successfully manufacture and commercialize the G4 and planned PX could have a substantial adverse effect on our business and results of operations; and (vii) the COVID-19 pandemic, efforts to reduce its spread and recent macroeconomic challenges have adversely impacted, and may materially and adversely impact, our business, operations and product manufacturing and commercialization objectives. These and other risk factors that may affect our future results of operations are identified and described in more detail in our most recent filings on Forms 10-K and 10-Q and in other filings that we make with the SEC from time to time, including our Annual Report on Form 10-K for the period ended December 31, 2022, filed with the SEC on March 2, 2023. Accordingly, you should not rely on forward-looking statements as predictions of future events or our future performance. Except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

 

Investor Contact

Matt Clawson

949-370-8500

ir@singulargenomics.com

 

Media Contact

Dan Budwick, 1AB

973-271-6085

dan@1abmedia.com

 

 

 

 

EX-99.1

 

img160378605_0.jpg 

Singular Genomics Systems, Inc.

Statements of Operations

(In thousands, except share and per share amounts)

 

 

Three Months Ended December 31,

 

 

Year Ended December 31,

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

(Unaudited)

 

 

 

 

 

 

 

Revenue

$

765

 

 

$

-

 

 

$

765

 

 

$

-

 

Cost of revenue

 

789

 

 

 

-

 

 

 

789

 

 

 

-

 

Gross margin

 

(24

)

 

 

-

 

 

 

(24

)

 

 

-

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

10,760

 

 

 

9,455

 

 

 

46,199

 

 

 

32,655

 

Selling, general and administrative

 

11,746

 

 

 

10,218

 

 

 

47,264

 

 

 

28,624

 

Total operating expenses

 

22,506

 

 

 

19,673

 

 

 

93,463

 

 

 

61,279

 

Loss from operations

 

(22,530

)

 

 

(19,673

)

 

 

(93,487

)

 

 

(61,279

)

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

(243

)

 

 

(192

)

 

 

(763

)

 

 

(846

)

Change in fair value of convertible promissory notes

 

-

 

 

 

-

 

 

 

-

 

 

 

(35,199

)

Change in fair value of warrant liability

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,180

)

Interest and other income

 

1,672

 

 

 

106

 

 

 

3,371

 

 

 

733

 

Total other income (expense)

 

1,429

 

 

 

(86

)

 

 

2,608

 

 

 

(37,492

)

Net loss

$

(21,101

)

 

$

(19,759

)

 

$

(90,879

)

 

$

(98,771

)

Net loss per share:

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted net loss per share

$

(0.29

)

 

$

(0.27

)

 

$

(1.28

)

 

$

(2.10

)

Weighted-average shares used to compute basic and diluted net loss per share

 

71,584,976

 

 

 

72,162,679

 

 

 

71,148,076

 

 

 

47,023,048

 

 

 

 

 

 

EX-99.1

 

img160378605_0.jpg 

Singular Genomics Systems, Inc.

Balance Sheets

(In thousands, except share and par value amounts)

 

 

 

December 31,

 

 

 

2022

 

 

2021

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

74,266

 

 

$

201,049

 

Short-term investments

 

 

170,310

 

 

 

138,174

 

Accounts receivable

 

 

913

 

 

 

-

 

Inventory

 

 

18,221

 

 

 

3,011

 

Prepaid expenses and other current assets

 

 

4,722

 

 

 

5,526

 

Total current assets

 

 

268,432

 

 

 

347,760

 

Right-of-use lease assets

 

 

45,896

 

 

 

-

 

Property and equipment, net

 

 

10,784

 

 

 

6,072

 

Restricted cash

 

 

1,711

 

 

 

687

 

Other noncurrent assets

 

 

1,152

 

 

 

1,129

 

Total assets

 

$

327,975

 

 

$

355,648

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

3,099

 

 

$

2,348

 

Accrued expenses

 

 

4,583

 

 

 

4,278

 

Lease liabilities, current

 

 

6,323

 

 

 

-

 

Other current liabilities

 

 

113

 

 

 

118

 

Total current liabilities

 

 

14,118

 

 

 

6,744

 

Lease liabilities, noncurrent

 

 

42,456

 

 

 

-

 

Long-term debt, net of issuance costs

 

 

10,065

 

 

 

9,904

 

Other noncurrent liabilities

 

 

1,015

 

 

 

2,827

 

Total liabilities

 

 

67,654

 

 

 

19,475

 

Commitments and contingencies

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

Series A common stock equivalent convertible preferred stock, $0.0001 par value; 7,000 shares authorized, 2,500 and no shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively

 

 

-

 

 

 

-

 

Common stock, $0.0001 par value; 400,000,000 shares authorized, 71,854,688 and 72,438,742 shares outstanding at December 31, 2022 and December 31, 2021, respectively

 

 

7

 

 

 

7

 

Additional paid-in capital

 

 

503,926

 

 

 

488,200

 

Accumulated other comprehensive loss

 

 

(837

)

 

 

(138

)

Accumulated deficit

 

 

(242,775

)

 

 

(151,896

)

Total stockholders’ equity

 

 

260,321

 

 

 

336,173

 

Total liabilities and stockholders’ equity

 

$

327,975

 

 

$

355,648

 

 

 

 

 GRAPHIC 3 img160378605_0.jpg GRAPHIC begin 644 img160378605_0.jpg M_]C_X 02D9)1@ ! @ 0 ! #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BJE]JECID7F7MU% O\ MMM@GZ#O7(:E\3=/@W)I]M)U3?<3QQ+ZNP'\Z\@OO'> MNW^0MPMLA_A@7!_/K6(9;B[ES(\LTA/\1+$T >OW7C30[7(%WYS#M"I;]>E9 M%Q\1H!D6UA(WH9'"_H,UQ]EX7UJ\P8M/E"G^*0;!^M;]K\/-0< W%S!"/1?>3R'N% 7_& MM*'P;HT76!Y/]^0_TH X5M9U.7[]_<'_ (&12?;+E_O7,I^KFO1X_#VD1_=L M(?Q&?YU872[!/NV5N/\ MF* /,EGE)YE?_OHU,D\HZ2O_P!]&O2Q8V@Z6L/_ M '[%!LK0];:'_OV* //8[RZ7[MQ*/HYJY'JM^G2[E_%LUV;:98MUM(?^^!43 M:+IS?\NJ#Z9% '.Q:]J"]90W^\HJ[%XCG_Y:0QM],BKS^';!ONB1/HW^-0/X M;3_EG<,/9ES0!-%K\#_ZR)T^G-7HM0M9ONS+GT;BL-]"NX_NE''L396TMQ*3D[1G'N3V_&O1=#^%38676;G'?R(#_ #;_ M H X$R76HW.YVFN9W/HYIT4CQGY6(K8J*2VBDY*X/J* (8KO/ M#C\15I65QE3FJ;6KIRIW#]:1"5/<&@"]14*3?WOSJ4$$9!S0 M%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%YNYTA@099W; %>3^*?BS),7M/#X,Q1-_SS':/R'- '?TR2:*%=TLB(OJS " MO(+OQQKM\2!="!#_ PKM_7K60]Q<73YFEDF<_WF+&@#V.X\3Z-;$A]0B)'9 M#N_E6=+XZTE/]6MQ+]$Q_,UY]::)JET 8;"X8'OL('YFMFW\%:U( 6ACB'^W M(/Z4 ;S^/H?^6=A(?]YP/Z5&?'4S?=L4'UD)_I5>+P'>_P#+2[@7Z FKD?@7 M'W[_ /*/_P"O0 P>-;HG_CTA_P"^C4B^,;D];6+\&-3+X)B'6]?_ +X'^-._ MX0V,=+QOQ0?XT ">+F/WK0?@_P#]:K,?BF!OOVTB_0@U6/A%A]V[!^J?_7IA M\,7:?=EB;\Q0!KQZ_8R=6=/]Y?\ "KD=]:S?1.OU6@#M,YZ45R,,\T7^KE=?H:T8=5N%P'VN/<8- &[15*+4X9.'!0 M^_(JVKJXRK CV- #J*** "FLBOU'XTZB@"NT17IR*:K%>AJU3&C#>QH %D#< M'@T^JY4J>:>KD<'D4 2T4 YHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **"0!DG %>-_$3 MXIX,VC>'IO5)[Q#^:H?Z_E0!N^//B?;Z%YFFZ.R7&I='DZI!_BWMVKQ3=J&N MZIDF:\OKA_=F$K4&,">_ M=<2W+#GZ+Z"@#FO!?PK@T\1W^O*D]U]Y+;JD?^]_>/Z?6O30 H X %+10 M 4444 %(2 "2< =2:Y?Q+X\TCPX&B:3[3>#I;Q')'^\>@_G7DVO>.-9\0LR2 MS^1:GI;PG"X]SU- 'JNN?$/1=(+112?;;D<;(3E0?=NG\Z\]U;X@ZWJQ9(YA M9P'^"#@X]VZUAZ)X;U779 MA:,Z=Y6^5%^IKTO1/A=96H6759VNI.OE1_*@_ M'J?TH \UM;6[U&XV00S7$S'G:"Q/UKK],^'.KW0#W;16B'LQW-^0_P :]3M+ M&TL(1#:6\4$8_AC4"K% '(V'P\T>U -P9;IQ_?;:OY#_ !KH[72["Q4"ULX( ML=U09_.K=% !1110 4444 %%%% !1110 48SUHHH @DLK:7[\*9]0,&JDFCQ M]8G9?8\BM*B@#$>PGB_AW#U6DC9D;@E36Y47*'\XU/\S^% $'Q-^)S7;S:%H4^+892 MYND/^L]54^GJ>]<)X3\)ZAXLU06EDFV)<&:=A\L2^_OZ"HO"'A._\7:NME:+ MMB7#3SD?+$OK]?05].>'_#]AX:TF/3]/BV1KRSG[TC=V8]S0 SPWX9T[PMIB MV6GQ8[R2M]^1O4G^E;%%% !117,^+O&VF>$K3-PWG7CC,5LA^9O<^@]Z -S4 M=2L])LGO+^X2"!!R[G]!ZGVKQOQ7\5+S5#)::+OM+3H9NDD@_P#91^M<7X@\ M4:IXHOC$C'L/ZUU7@[X9WVN".\U+?9V!Y (Q)*/8=A[F@#F-* MTG4-YJ]0 R*&*")8H8UCC4854& /PI]%% !1110 444= M.M !16?=:[I5ED7%_ A'\._)_(5D3^.]'C)$1FF/^PF!^M '3T5QM25 5*GFGJV/I0!)11UHH *JZD;Q=-N6TY(WO1&?)64X4MCC-6J* /DK4K M_6K/Q-->WLUQ#J\4VYW8X=7']/TQ7O7P[^(<'BVT^R7A2'5XE^=!P)1_>7^H M[4_XA?#ZW\6V1N;4)#JT2_NY.@E']UOZ'M7SINU'P_K&1YMGJ%I)]&1A0!]A MT5Q?P]\>V_C+2]DI6+5+=0)X1_%_MK[']*[2@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBN4\?^,[?P9X?>Z)5[Z;*6 ML)_B;U/L.IH YGXL?$3^P+1M$TN7_B9SK^]D4_ZA#_[,>WIU]*\0\.:!?^*- M:ATZQ0M+( /!-OX,T18B%DU"< M!KF8=S_='L* -/POX9L/"FC1Z=8ITYEE(^:5^['_ #Q6U110 445YI\2OB4G MAY'TC2'5]4=<22#D6X/_ +-[=J +GC_XDVWAA'T_3REQJS#IU6#W;W]J\(:7 M4->U4NYFO+ZY?_>9R:CTW3]1\0ZLEM:QR75Y<-DDG))[L3Z>IKZ)\#^ ;+PE M:"5PMQJ/Z5Z7110 M4444 %%%W1/+]INQ_RPA.2#_M'H* .GK#U;Q=HNC96YO%:8?\ M+*+YV_3I^->2:WX_UK6RT:S?9+8_\LH#C(]VZFLK3-*O]6F\NRM99W[E1P/J M>@H [S4?BA=3$IIMFD*]I)CN;\NG\ZYF\U_5=2)-W?S.#_"&VK^0XKIM)^&% MRX5]3NUA'>.'YF_/I_.NST_P=H>G &.R65Q_'-\Y_7B@#R:SL+R\;%M:S3'_ M &$)KH+3P7K<>=>0K[*I/^ M%7X_ D:_?OW/^[&!_6NPHH YA?!5JO\ R]S'\!3_ /A#[<=+J7_OD5TE% '- M'PF!]R[/XI_]>F'PU=)]R6)_S%=110!R3:5>P_>@)'JIS355XVY#*WOQ77TU MXTD&'4,/<9H P8+ZXCX$A8>C@"S12*P8<&EH **** #K3"F.G2GT M4 -6G9&<=ZJZA?N$?UZYH ^G**Y[PAXOL/&&D"[M#LF3"SP$_-&W]1Z&NAH *\[^)OP\3 MQ/9-J6G1JNKP+T''GJ/X3[^A_"O1** /CK2]5U#PWK45]9NT%W;/R",?56'I MV(KZE\'>+++QAH,>H6I"R#Y9X<\Q/W'T]#7G/Q@^'OGQR^)M)A_>J,WL*#[P M_P">@'J._P"=>7^"/&-UX,\01WL6Y[63"7,(/WT_Q'44 ?6U%5M/O[;5-/@O MK.59;:= \;KW!JS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 5M0O[;2]/N+Z\E$5M ADD<]@*^2O&OBVY\8^(YM1F++ /DMHB> M(XQT_$]37H/QQ\;_ &J['A:PE_LI^\_9/PZGWQZ5SGPF\$'Q7X@^UWD M9.EV+!YI0XO;E?\ 1D8W+Y))R23U9CZ=R:K MM)J/B'62[F2[U"\E^K.QKZ5^'O@2W\':4'F"R:I.H,\O7;_L+[#]: +7@CP1 M9>#],"(%EOY5'VBXQR3_ '1Z**ZJBB@ HHHH *HZMK%AHEBUYJ-RD$*]V/+' MT [FL#QEX]T[PE;^62+C47&8[93T]V/8?SKP;6?$&I>)-0-WJ,[2N3A$'"H/ M11VH [3Q3\4=0UAGM=*WV5D>"X/[V0>Y_A'L*Y;2-'U'7+OR+"VDGD)RQ'1? MJ+'>ZSOM+0\K#TDD'_LH_6O8].TRRTFT6UL+:."%?X4'7W) M[F@#A?#WPLM+4+/K,OVF7KY,9(0?4]3^E=_;6MO9P+#;0QPQ+T1% J:B@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH :\:O]Y0:A-N5^Z]N_UKUJB@#Y%\/>(M0\*ZS'J-@Y61#B2-ONR+W5A_G% M?4'A?Q-8>*]%BU*Q?@_++$3\T3]U/^>:\M^+7PY"";Q)HT/R_>O($'3_ *:* M/YC\:\Z\$^,KOP9KJ7<1:2TDPMS!GAU]1[CM0!]8T55TW4;75].@O[&99;:= M Z..X_QJU0 C*KJ58 J1@@C@BOF7XK>!#X5UG[=91G^RKQB8\=(GZE/IW'_U MJ^FZS/$.A6?B30[K2KY,PSK@''*-V8>X- 'AOP8\=G2M1'AO49<65T_^C.QX MBE/\/T;^?UKZ%KXP\0:+>^&=>N=,NP4N+9^&'&X=58>QTI\*_&H\7^&52 MYD!U.R BN!W36EUXAM8KB%S'(C! MLJP.".E);_%'P3=W,5M!XBM))I7$<: -EF)P!T]: .NHHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BLG7O$^B^&(89M:U"*RCF8I&TF?F(&<<"L M+_A;/@3_ *&6S_)O\* .SHK/T;7-,\0Z>+_2;V*[M2Q7S(SQD=16A0 4444 M%%%(S!5+,< #)- "T5QI^*_@0$@^)+3(X/#?X5=TCX@>%->U&/3]+UNWNKN0 M$K$@;) &3U'I0!TM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%<_KGCGPQXHW>.\< 4' M_OHB@#UBBO&%_:0\.%\/I&IJOJ-A_3=6YIOQW\#Z@ZI+>7-DQ_Y^8"!^:YH M]+HJCI>M:9K5N+C2]0MKR+^]!(&Q]<=*O4 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 445B:]XO\ #_AAX$UK5(;)IP3$),_,!C/0>XH VZ*X MS_A;/@3_ *&6S_)O\*Z;2=7L-=TZ/4-,NDN;27.R5,X.#@]?<4 7:*** "BB ML77O%V@>&&@76M3ALC."8A)GYL8SC ]Q0!M45QG_ MGP)_T,MG^3?X5TVDZ MO8:[IT>H:9=)AH Z:B MN/C^*O@:65(T\269=V"J/F&2?PKL.M !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !17(3?%/P1;SR03>(K1)8V*.I#<$'!'2H_P#A;/@3 M_H9;/\F_PH [.BN,_P"%L^!/^AEL_P F_P *5?BOX$8X'B6S_'%+G425-RP\JV0_P 4AZ?@.I^E=/7RU\9/%_\ PDGB][*VDW6& MFDPQX/#R?QM^?'X4 <99VU]X@UN.WBWW%]>S8R>2SL>2?YU]>^$O#=MX4\.6 MNDVP!\M1\\PV88?]]O\ T'XU[G0 4444 M 4M7U:TT/2;G4KZ41VUNA=SZ^@'N>E?)GBSQ1>>+_$$^IW1(5CMABSQ$@Z*/ MZ^]=G\9_')UK6/\ A'["7-A8O^^93Q+,/Z+T^N:C^#W@7_A(=6_MB_BSIMDX MVJPXFEZ@?0=3^% '>?"+X?C1K%-?U.'_ (F%PF8(V',,9[_[Q_05ZK110 44 M44 %>=_$/XE0^&T?3-,9)M58?,>JP ]SZM[?G3/B9\1T\,V[:5IDBOJTJ_,P MY%NI[G_:]!^->$Z98:CXAU=+6U22YO;A\DDY))ZLQ]/4T 3PIJ.O:L%437E] MI]_RK5\$>!;'PA8@X6?49%_?7 M!'_CJ^@_G764 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 PICD5%ZL*^F_"?BJP\7:,E_9-AA\LT)/S1/Z'^A[T ;M%%% " M,JNI5@&4C!!&017S;\5O )\,:G_:6GQG^R;I^ .D+_W?H>WY5])U1UC2;37- M)N=-OHA);SH58=QZ$>XZT ?/_P (?'QT#5!H>HRXTR[?]VS'B&4]_H>_YU]' M5\=>+?#=WX3\0W&EW0)V'=%)CB1#T8?YZU[U\'O'/_"2Z%_9=]+G4[!0I+'F M6+H&^HZ'\/6@#TNBBB@#ROXU>"O[;T+^W+*+-_8*3(%',D/?\1U_.O$? OBN M;P=XJMM24L;8GR[F,?QQGK^(ZCZ5]@LJNA1@&5A@@]"*^2OB?X1/A'Q=/!$A M%A7PF7T30RDNL,O[V4\K; M]..[>W:O0/&/B!/"WA'4M98 M;0DQJ?XG/"C\R*^([R[N-0O9[RZE:6XGR7FH74UU"O!U_P"-_$46E6.$&-\T M[#*Q(.K'^0''O@_X-T"V1#I<5_< ?-<7@\PL?8'@?@* /CRG*S(P925 M8'((."*^T-4^&/@S5[9H;CP_91Y&!);QB)U^A7%?,WQ,^'EQX!UQ(ED:?3;H M%K6=ASQU5O<98AV^J_R^E 'LU%%% !45S_ M ,>DW^XW\JEJ*Y_X])O]QOY4 ?!,W^OD_P!X_P Z]#^!?_)5M._ZY3?^@&O/ M)O\ 7R?[Q_G7H?P+_P"2K:=_URF_] - 'UQ1110 4444 %%%% !1110 4444 M %%%% !1110 445S7CCQG8>!_#LNIWGSR'Y+> '!ED[#Z=R>PH F\6>,M&\& M:6;[5[D)G(BA7F24^BC^O05\U>,_C5XD\3R26]C*VE:<<@16[8D)?$NJ>+-9EU35;@RS.?E7^&->RJ.P%94<3S2+'$C/(YPJJ,DGT H 1F9V M+.2S$Y))R325[%X/^ &LZQ%'>:_XZ+^//M7K&E_!'P-IL8 M#Z8]ZXZO=3,V?P&!^E 'R+17V>_PL\#2)M;PS8@?[*D'\P:Y37?V??"FHQLV MER7.F3G[NQ_,CS[JW/Y&@#YFT[5+_2+M;K3KR>TG4Y$D+E3^E>W>!?V@9HY( MK#Q<@DC.%%_"N&7_ 'U'4>X_*O./&WPQ\0^!Y#)>P"XL"<)>0 E/HW=3]:XV M@#[WL[RVU"SBN[.>.>WE4-'+&VY6'J#4]?(OPO\ B?>>!]22UNG>?0YW_?0Y MR8B?XT_J.]?6EI=07UI#=VLJS6\R!XY$.0RGD$4 34444 %%%% !1110 444 M4 %%%% !1110 4444 %?/'[2W_(1\/?]#U]>_!+_DE.D_67_P!&-7R%7U[\$O\ DE.D_67_ -&-0!Z%1110 5\^?M+_ M /'SX<_W)_YI7T'7SY^TO_Q\^'/]R?\ FE '@E?7GP2_Y)1I/UE_]&-7R'7U MY\$O^24:3]9?_1C4 >A4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !VKX-U?_D-7_P#U\2?^A&OO+M7P;J__ "&[_P#Z^)/_ $(T ;WPS_Y*7X=_ MZ_4_G7VI7Q7\,_\ DI?AW_K]3^=?:E !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110!2UC4[?1=&O-3NF"P6L+2N?8#.*^&]9U2XUO M6KW5+IMT]U,TK^V3T_#I7T3^T/XH^P>'+3P_!)B;4'\R8 ](D/3\6Q^1KYIQ MDXH .AXK[+^%?B?_ (2KP!I]W(^ZZ@7[-<>N].,GZC!_&OC0J58JP((X((Z5 M[)^SUXG_ +.\47.@SOB#44WQ G@2H,_JN?R% 'TU1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% 'PEX@_P"1EU7_ *_)?_0S6=6CX@_Y&75? M^OR7_P!#-2^%]+AUOQ5I>EW#ND-WVVJ^?*GC.Z.4>Q_H M>: /6_AY\>IC6BS@K_P !)&/8^U 'MM%%% ''?$WQ4/"7 M@J[NXW O)Q]GMAWWL.OX#)_"OE?P]HUSXC\06>E6^3-=2A2QYP.K,?H,FN\^ M.OBC^V/&2Z3 ^;72UV$ \&5N6/X# _ UT_[/OA?Y;SQ-<1\G-M:DC\78?H/S MH ]JTK3;;1M*M=-LT"6]M&(T'L._U[U+J_&V#<.4A]?^!'GZ 5ZY0 4444 %<9\1?'4/@S M1OW1634[D%;:(]O5S[#]370Z_KEGXDT %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% 'CGQ6^' FCF\0Z+#B1^#]/BYX _L&\.MZ9%C3;A_P![&HX@D/\ [*?T- 'O.C:O M9Z]I-OJ5A*)+>==RGN/4'T(Z5>KYG^%/CP^%M;&G7TI_LF]&FN;6/.IV(,D.!S(O\2?U'N/>OG' MPWX@N_"OB*UU:U)WP/\ .G3>AX93]17V=7S!\9?!_P#PCGB@W]K'MT_429%P M.$D_B7^H^OM0!])Z3J=KK6DVNI6<@>WN8Q(A]CV^HZ5_\:#^?YU[Q0 5P7Q;\)CQ/X,F>&/=?6&;B# Y8 ?,OXC]0*[V@C(P> ME 'Q;X2\13^%?%-CJ\).(9/WJC^.,\,/RK[,M;J&]M(;JW4?M"7#P_#=(E)Q-?1JWT 9OY@5\KU]=?&_2)-6^&-\ MT*EI+-TNL#T4X;]"3^%?(U 'T7^S7:0#1=X4+D#\R:]SKY)^# M_P 0X? ^NSP:CN_LJ^"K*RC)B<='QW')!_\ K5]6V.H6>J6<=Y8W,5S;2#*2 MQ,&4CZB@"S7#?%;P9<>-O!QL+%8C?PS)+ 9&VCT89^A/Y5W-% 'RE_PS_P". M/^>>G_\ @5_]:O6?@SX%\0>!XM6@UE;<17+1O%Y,N_YAN!SQ[BO5** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@#X?\;_\ (]Z__P!A";_T,U!X4_Y' M#1?^OZ'_ -#%3^-_^1\U_P#["$W_ *&:@\*?\CAHO_7]#_Z&* /N>BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH \/_:4_P"1>T/_ *^I/_0*^<*^ MC_VE/^1>T/\ Z^I/_0*^<: -:_\ #M]I^@Z9K,B;K+4 XCD'0,K$%3[\9_&J MND:K=Z'JUKJ=A*8KJVD$D;#U'8^QZ5])?#_PO9>,/@)::/>@ 2F8Q28YBD$C M;6'T_EFOG'7-%O?#VM76E:A$8[FVD*,.Q]"/8CD4 ?9G@GQ;9^-/#%MJUJ0K ML-D\6>8I!U7^H]B*Z*OC_P"%'CY_!'B=?M#M_9-X1'=)V7TD'N/Y9KZ^CD2: M))8G5XW4,K*<@@]"* '5%<_\>DW^XW\JEJ.X!:VE ZE"/TH ^")O]?)_O&O0 M_@7_ ,E6T[_KE-_Z :\\GXN)!_MG^=>A_ O_ )*MIW_7*;_T T ?7%%%% !1 M110 4444 %%%% !1110 4444 %%%% ",P52S$ 9)/:OCKXJ^-9/&?C&>6*0 MG3K0F"T7/!4'E_JQY^F*^C?B[X@;P]\.-2GB07X)_[YW5\=4 * MJ-(ZHBEF8X R2:^I_A+\*;;PK80ZQJ\"RZW,H95<9%J#V'^UZG\*\M^ _A) M-?\ &+ZI=1A[32E$@##AI3]S\L$_@*^J* "BBB@ HHHH BNK6"]M9;:ZA2:" M52KQR+E6![$5\L?%GX5R^$=1&HZ/#)+HUT^%506-N_\ =/MZ'\*^K*" 1@C- M 'P3]@O/^?2?_OV?\*^@/V?O%=YY5QX5U%)@L:F>R:12,#^),GZY'XU[IL7^ MZ/RI0J@Y"@?A0 M%%% !1110 4444 %%%% !1110 4444 %%%% !7SQ^TO\ M\A'P]_URG_FE?0]?/'[2W_(1\/?]!U]>_!+_DE&D_67_T8U?(=?7GP2_Y)1I/UE_]&-0!Z%1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 ':O@W5_^0W?_ /7Q)_Z$:^\N MU?!NK_\ (:O_ /KXD_\ 0C0!O?#/_DI?AW_K]3^=?:E?%?PS_P"2E^'?^OU/ MYU]J4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(2 "2 M< =2:6N%^+OBC_A%_A_?2Q2;;N['V6WP>"4U:%,W&E MR;V('/E-PWY':?P-?+= 'WAHNJP:YHEEJEJP,-U"LJ^V1T_#I5ZO%OV=_$_V M[P[=^'IWS-8/YL()ZQ.>1^#9_P"^J]IH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@#X2\0?\C+JG_7Y+_Z&:T_A]_R43P]_P!?\/\ Z$*S/$'_ M ",NJ_\ 7Y+_ .AFM/X??\E$\/?]?\/_ *$* /MJBBB@ K"\8>%[+QAX:NM( MO$4^8I,4A',4@^ZP_']*W:* /@B^LYM.O[BRN%VSV\K12+Z,IP?Y5T?PUUAM M#^(FBW@8JAN5BD]T?Y3_ #JS\68HX?BEKZQ8VFX#''J5!/ZDUR^DASK-B$^^ M;B/;]=PH ^\ZRO$FM1>'?#>H:O,1MM8&D /=L?*/Q.!6K7B_[0_B#[)H&GZ# M$^'O9?.E _YYIT'XL?TH \ !N];UC)W2WE[/^+.[?XFOM'PQHD/ASPUI^D0@ M;;:$(Q'\3=6/XG)KYN^!OA[^V?'L=[*FZWTV,SG/3>>$_7)_"OJ>@ HHHH \ MX^-'BO\ X1WP5):02;;W4B;>/!Y5,?.WY+/%MEI2@^2S;YV' M\,:\M_A^-;'Q@\3'Q'X^NDBDW6FG_P"BPX/!(/SG\6S^0KU+X!^&/L'AVXU^ M>/$]^VR$D-SX@U_P#L:RESIVGN0Q4\2R]" M?H.@_&KWP8\##5]0_P"$AU"+-E:/B!&'$LH[_1?YUYMX9T.Z\3^(;32K7)EN M),,YYVKU9C]!DU]A:/I5KH>D6NF6482WMXPBCU]2?-_"MSX0\1SZ;-EHOOV\I'^LC/0 M_7L?<5[9\%_&YU[13H=]+NU"P4>6S'F6'H#]1T_*MCXJ>#1XL\+2/;Q@ZE9 MRVY Y8?Q)^(_4"OFGP[KUUX7\1VFK6I(DMY,LG3>O1E/U&: /M&BJFEZE;:Q MI5KJ-FX>WN8Q(C>Q%6Z "N8\?^%T\7>$+S3MH^TA?-MF/\,B]/SZ?C73T4 ? M$6FZC>>'M=MK^WS'=6')WR]LWVBW!/ M\#'##\#@_P# J /;:*** /*?CQX:_M7P>!]:DEBC>71KAR;:<#(3/\ WH1 M^M?8-5[ZPM-3LI;.^MX[BVE7:\4J[E8?2@#X(K;\/^+M>\*W/G:-J4]J2%KT6Y.3]CNB2GT5^H_'/UKQOQ!X"\4>&&8ZKH]Q M%$#CSD7?&?\ @2Y% 'K'AO\ :.D79#XDTH..AN;(X/U*'^AKV/PWXV\/>+8! M)H^IPSOC+0D[9%^JGFOB"IK:YGL[A+BVFDAF0Y22-BK*?8B@#[YHKYY^'/QW MGCFATKQ=)YD+$+'J./F3T\P=Q_M?G7T(CI+&LD;!D8 JRG((/<4 .HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH ^'_&__ "/FO_\ 80F_]#-0>%/^1PT7 M_K^A_P#0Q4_C?_D?-?\ ^PA-_P"AFH/"G_(X:+_U_0_^AB@#[GHHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** /#_VE/\ D7M#_P"OJ3_T"OG"OH_] MI3_D7M#_ .OJ3_T"OG"@#Z\^"'_)*-*_WI?_ $8U8WQP^'O_ D6C?V_IL.= M3L$/F*HYFA')'N5ZCVS6S\$/^24:5_O2_P#HQJ]#(R,'I0!\ U]&? 7XA?;K M0>$M3FS<0*6L78\O&.J?4=1[?2N%^-/P]/A37_[6T^+&DZ@Y8!1Q#+U*>P/4 M?B.U>:Z??W.EZA;W]G,T-S;R"2.1>JL* /O:FR_ZI_\ =-./"T M&I1;4N5_=W4(/^KD Y_ ]1742_ZI_P#=- 'P/%_M*7I32="L >))Y)6'^ZH _]"-?.M>]_M+(W MVGP\_P##LF'XY2O!* /J?]GS34M/ATUYMQ)>7O._@>ZO\*= M+V_PO,#]?,:O1* "BBO&_C%\3/$'@?7M/L](-KY4]L97\Z+>=VXCCD>E 'LE M%?*G_#07C?UTW_P&/_Q5'_#07C?UTW_P&/\ \50!]5T5\J?\-!>-_73?_ 8_ M_%4?\-!>-_73?_ 8_P#Q5 'U717RI_PT%XW]=-_\!C_\51_PT%XW]=-_\!C_ M /%4 ?5=%<=\,/$FH^+/ UKJ^J>5]IEDD4^4FU<*Q X_"NQH **** "BBB@ MHHHH **** "BBB@ HHHH *^>/VE_^0CX>_ZY3_S2OH>OGC]I?_D(^'O^N4_\ MTH \'KZ]^"7_ "2G2?K+_P"C&KY"KZ]^"7_)*=)^LO\ Z,:@#T*BBB@ KY\_ M:7_X^/#G^Y/_ #2OH.OGS]I?_CY\.?[D_P#-* / Z^O?@E_R2C2?K+_Z,:OD M*OKWX)?\DHTGZR_^C&H ]"HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** #M7P;J__ "&[_P#Z^)/_ $(U]Y=J^#=7_P"0W?\ _7Q)_P"A&@#>^&?_ M "4OP[_U^I_.OM2OBOX9_P#)2_#O_7ZG\Z^U* "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "OESX_^*/[7\91Z-!)FVTM-K '@RMRWY# M_.OH[Q+K<'ASPWJ&L7!'EVL+28/\3?PC\3@5\.WU[/J.H7%[::18T4=V)P*^X_#.BQ>'/#6G:1"!MM8%C)'\38^8_B< MFOF;X$>&_P"V_'Z7\J;K;2T\\YZ>8>$'YY/X5]74 5M1L8-3TVYL+E0T%S$T M4@/<,,&OAK7M(GT'7K_2KD$2VD[1'WP>#^(P:^[J^:?VB/#7V'Q)9Z_"F(K^ M/RI2/^>J=/S7'Y4 <+\,O$Q\*>/-.OW?;;2/Y%QZ>6_!/X'!_"OM $$ @Y!K MX!K[%^$GB?\ X2CX?V$\C[KNU'V6XR>=R]"?JN#0!W-%%% !1110 4444 %% M%% !1110 4444 %%%% !1110!\)>(/\ D9=5_P"OR7_T,UI_#[_DHGA[_K_A M_P#0A69X@_Y&75?^OR7_ -#-:?P^_P"2B>'O^O\ A_\ 0A0!]M44R66.")I9 M9%CC099W. H]2:SG\3:#&,OK>FJ/>Z3_ !H U*AO+N"PLYKNYD6."!#)(['A M5 R37,:E\3O!>E1LUQXBLF*_P0/YK'\%S7A/Q1^,LGBZV;1M%CEMM))_?22< M27&.@('1?;O0!YSXFUAM?\3ZGJS C[7RD\#\L5M?"[17U[XC:-:A-T< M/E^]_P"/$U]6:QJ$>DZ+?:C*0$M8'F.? M]E2?Z5\.EY]5U-G.7N+N;/N69O\ $T ?37P#T+^S? KZE(F)M2F+@G_GFORK M^NX_C7JM9V@Z7'HOA_3],B "VMND7'<@\1OE7]2*Z&O#/VC->,5CI6@1OS,YNI@/[J_*OZD_E0!X=I&GW.NZY:6$67 MN+R=8P?=CR?ZU]LZ7I\&DZ5::=;+M@MHEB0>P&*^!+^\C?;=3+]GM_7>_&?P&3^%?*WA?19O$GB2PTF'.^ZF"LW]U>K M-^ R: />/@1X2%AHLOB.ZC_TB]_=V^1RL0/)_$_H*]AJ"RLX-/L8+.V0)!!& ML<:CLH&!4] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !7RW\9/"?_".>+GN[>/;8ZCF:/ X5 M_P"-?SY_&OJ2N)^*OA@>)_ UY'&FZ[M!]IM^.*_.M;OP MQ'-Q:Y/\!/SJ/H<'\37M]?%/A77Y?#'BO3]7B)Q;R@R*/XD/##\B:^TH M)X[JWBN(7#Q2H'1AT((R#0!)1110!YY\9_#G]O> +F>--USIQ^TQX'.T??'_ M 'SS^%?.WP^\0GPQXZTO42VV#S1%/[QO\I_+.?PK[)FA2X@DAE4-'(I1E/<$ M8(KXE\5:,_A_Q1J6DN"/LUPR*?5_X2+X?: M3>N^Z98O(F/^VGRG\\ _C76T %?,?Q_T+^SO&L.J1IB+48 6('_+1/E/Z;:^ MG*\K^/FB_P!H^ !?HN9=.N%DS_L-\K?S'Y4 8/[.>N^;INJZ%(_,$@N8@?[K M<-^H'YU[E7R-\&=9_L?XFZ<&;;%>AK5_?KTC*KJ590RG@@ MC(-9GAS7[+Q1H-MK&G^9]EN 2@D7##!(.1]16I0!P7BCX/\ A'Q.KR&Q%A>- MR+BS 0Y]U^Z?RKYR\?\ PTUCP%=J;G%SI\K8ANXQ@$_W6'\+5]E5SOCO1[?7 M? ^L6%P@96MG="1]UU!92/Q H ^(J^EOV??&,VJZ-<^'+V4O-IX$ENS'),). M-O\ P$_H:^::].^ EP\/Q1MHU)VSVTR,/4!=W\U% 'UC1110 4444 %%%% ! M1110 4444 %%%% !1110!\/^-_\ D?-?_P"PA-_Z&:@\*?\ (X:+_P!?T/\ MZ&*G\;_\CYK_ /V$)O\ T,U!X4_Y'#1?^OZ'_P!#% 'W/1110 4444 %%%% M!1110 4444 %%%% !1110 4444 >'_M*?\B]H?\ U]2?^@5\X5]'_M*?\B]H M?_7U)_Z!7SA0!]<_ PD_"C3,GI),/_(C5Z-7G'P+_P"24:;_ -=9O_1C5Z/0 M!E>)/#]EXHT"[TC4$W07"8SCE&[,/<'FOBWQ/X=OO"GB&[T>_3$T#X#8XD7^ M%A[$5]SUYC\9OA\/%WA[^T;"('5[!2T8 YFCZE/KW'O]: / _AEXZF\#>*8[ MEV9M.N,17D0[KV8#U7K^8K[#CN(;NQ6YMY%EAECWHZG(92,@BO@@@J2",$<$ M&O?O@1\0=T+>#]3FY"LVGNQ[=3'_ %'XB@#P6X_X^I?]\_SKT+X%_P#)5M._ MZY3?^@&O/KD$7

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end EX-101.LAB 4 omic-20230302_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, City or Town Entity Address, City or Town Soliciting Material Entity Ex Transition Period Entity Ex Transition Period Amendment Flag Amendment Flag Document Quarterly Report Document Quarterly Report Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Small Business Entity Small Business City Area Code City Area Code Document Period End Date Document Period End Date Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Fiscal Period Focus Document Fiscal Period Focus Entity File Number Entity File Number Current Fiscal Year End Date Current Fiscal Year End Date Entity Address, Address Line One Entity Address, Address Line One Entity Information, Former Legal or Registered Name Entity Filer Category Entity Filer Category Entity Current Reporting Status Entity Current Reporting Status Entity Tax Identification Number Entity Tax Identification Number Entity Emerging Growth Company Entity Emerging Growth Company Document Transition Report Document Transition Report Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Registrant Name Entity Registrant Name Pre-commencement Tender Offer Title of 12(b) Security Title of 12(b) Security Entity Address, State or Province Entity Address, State or Province Document Type Document Type Entity Shell Company Entity Shell Company Written Communications Security Exchange Name Security Exchange Name Entity Address, Address Line Two Entity Address, Address Line Two Entity Central Index Key Entity Central Index Key Entity Interactive Data Current Entity Interactive Data Current Local Phone Number Local Phone Number Pre-commencement Issuer Tender Offer Document Fiscal Year Focus Document Fiscal Year Focus Cover [Abstract] Trading Symbol Trading Symbol EX-101.PRE 5 omic-20230302_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 6 omic-20230302.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document and Entity Information
Mar. 02, 2023
Cover [Abstract]  
Entity Registrant Name Singular Genomics Systems, Inc.
Entity Central Index Key 0001850906
Document Type 8-K
Entity Information, Former Legal or Registered Name N/A
Document Period End Date Mar. 02, 2023
Amendment Flag false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Trading Symbol OMIC
Entity File Number 001-40443
Entity Tax Identification Number 81-2948451
Entity Address, Address Line One 3010 Science Park Road
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92121
City Area Code 858
Local Phone Number 333-7830
Written Communications false
Soliciting Material false
Pre-commencement Issuer Tender Offer false
Pre-commencement Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Security Exchange Name NASDAQ
Entity Incorporation, State or Country Code DE

XML 8 omic-20230302_htm.xml IDEA: XBRL DOCUMENT 0001850906 2023-03-02 2023-03-02 0001850906 false 8-K 2023-03-02 Singular Genomics Systems, Inc. DE 001-40443 81-2948451 3010 Science Park Road San Diego CA 92121 858 333-7830 N/A false false false false Common Stock, par value $0.0001 per share OMIC NASDAQ true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports omic-20230302.htm omic-20230302.xsd omic-20230302_lab.xml omic-20230302_pre.xml omic-ex99_1.htm http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "omic-20230302.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 24 }, "contextCount": 1, "dts": { "inline": { "local": [ "omic-20230302.htm" ] }, "labelLink": { "local": [ "omic-20230302_lab.xml" ] }, "presentationLink": { "local": [ "omic-20230302_pre.xml" ] }, "schema": { "local": [ "omic-20230302.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 37, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "omic", "nsuri": "http://singulargenomics.com/20230302", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "omic-20230302.htm", "contextRef": "C_f153ce72-2e66-4d7f-a592-ca3aba86b027", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "omic-20230302.htm", "contextRef": "C_f153ce72-2e66-4d7f-a592-ca3aba86b027", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationFormerLegalOrRegisteredName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Former Legal or Registered Name of an entity", "label": "Entity Information, Former Legal or Registered Name" } } }, "localname": "EntityInformationFormerLegalOrRegisteredName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://singulargenomics.com/20230302/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0000950170-23-005815-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-23-005815-xbrl.zip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end